Three-year outcomes with the fully repositionable and retrievable lotusTM transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: Results from the REPRISE II CE-mark study.

MLA

Houle V., et al. Three-Year Outcomes with the Fully Repositionable and Retrievable LotusTM Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305133111&authtype=sso&custid=ns315887.

APA

Houle V., Walters D., Dumonteil N., Worthley S., Tchetche D., Manoharan G., Blackman D., Rioufol G., Meredith I., Hildick-Smith D., Whitbourn R., Lefevre T., Lange R., Mueller R., Redwood S., & Allocco D.J. (2017). Three-year outcomes with the fully repositionable and retrievable lotusTM transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: Results from the REPRISE II CE-mark study.

Chicago

Houle V., Walters D., Dumonteil N., Worthley S., Tchetche D., Manoharan G., Blackman D., et al. 2017. “Three-Year Outcomes with the Fully Repositionable and Retrievable LotusTM Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients with Severe Aortic Stenosis: Results from the REPRISE II CE-Mark Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305133111&authtype=sso&custid=ns315887.